Deadly MERS infections unlikely to reach epidemic levels

Image
ANI Washington
Last Updated : Dec 12 2014 | 10:56 AM IST

A new study has suggested that it is possible to stop Middle East respiratory syndrome coronavirus (MERS-CoV), which is a viral respiratory illness first reported in Saudi Arabia in 2012, from reaching pandemic or even epidemic status.

In three new studies in the current issue of the, researchers reported on clinical outcomes in the Kingdom of Saudi Arabia (KSA), how long patients will shed virus during their infections, and how the Sultanate of Oman is dealing with cases that have appeared there.

An editorial in the same issue discusses how the relatively high percentage of infections has been hospital-acquired, which reduces the possibility that MERS-CoV, which exhibits a 40 percent fatality rate and over 97 percent of the cases have occurred in the Middle East, will reach pandemic or even epidemic status.

This research team notes that although healthcare exposure to infection was the most important risk factor for the development of MERS-CoV infection, in the ICU setting, where more strict infection control measures were applied (single rooms, dedicated 1:1 nurses, and better compliance with hand hygiene and isolation precautions), only one healthcare worker acquired the infection and no patient-to-patient transmission occurred.

Researcher Ziad A. Memish said that these findings, if confirmed by the prospective systematic collection of respiratory samples, would highlight the importance of applying prolonged infection control measures in severely ill patients with MERS-CoV in the healthcare setting.

Lead author I.S. Al-Abaidani said that strengthened infection control practices and having a powerful active surveillance program for acute respiratory illnesses are key to the rapid and prompt response for emerging respiratory infections.

According to the editorial, with most infections occurring in hospital settings, there is a large potential to reduce transmission through early identification of possible MERS-CoV infected patients thereby leading to early isolation of these patients, ideally at the arrival point in the hospital.

.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 12 2014 | 10:48 AM IST

Next Story